Phytochemical Investigation and Cytotoxic Profile of Genistein Isolated from the Cytisus scoparius Linn. on Topoisomerase II

Article ID: e070122200100 Pages: 10

  • * (Excluding Mailing and Handling)

Abstract

Background: Genistein is one of many new cytotoxic drug leads that have been discovered recently. It is a well-studied chemopreventive drug that has attracted the attention of the scientific community due to its favourable effects on grave illnesses in humans such as cancer.

Objective: The present study focuses on the methanolic extraction, isolation, and characterization of an isoflavone, genistein, from the weed plant of Cytisus scoparius Linn. (family: Fabaceae).

Methods: The phytochemical structure of genistein was confirmed by its spectral and chromatography analysis through IR, HPTLC, LCMS, NMR, etc. The total flavonoid fraction of methanolic extracts containing genistein was evaluated for in-vitro cytotoxic activity on cervical cancer HeLa cells using MTT assay, cell cycle analysis, and topoisomerase II inhibitory activity.

Results: The result of the in-vitro cytotoxicity study showed the IC50 value of 4.5 μg/ml, which shows that the isolated compound is cytotoxic. The result of cell cycle analysis revealed the cell arrest at a sub-G phase, which shows that the isolated compound was apoptotic. Moreover, the human topoisomerase II assay proved that it is an excellent human topoisomerase II inhibitor at 10 μg/ml.

Conclusion: These findings revealed that genistein increased cytotoxicity and cell arrest owing to human topoisomerase II inhibitory activity and thus it may be an anti-cancer component. The relationship between the phytochemical structural analysis of this compound and its bioactivities is discussed.

Keywords: Apoptosis, isoflavone, weed, Cytisus scoparius, cervix HeLa cell lines, topoisomerase II.

Graphical Abstract

[1]
Crawford, S. Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Front. Pharmacol., 2013, 4, 68.
[http://dx.doi.org/10.3389/fphar.2013.00068] [PMID: 23805101]
[2]
Kinghorn, A.D.; Chin, Y.W.; Swanson, S.M. Discovery of natural product anticancer agents from biodiverse organisms. Curr. Opin. Drug Discov. Devel., 2009, 12(2), 189-196.
[PMID: 19333864]
[3]
Singh, R. Medicinal plants: A review. J. Plant Sci., 2015, 3, 50-55.
[4]
Mittermeier, R.A.; Gil, G.P.; Hoffman, M.; Pilgrim, J.; Brooks, T.; Mittermeier, C.G. Hotspots revisited: Earth’s biologically richest and most endangered terrestrial ecoregions; University of Chicago Press: Boston, 2005, p. 392.
[5]
Chaitanya, M.V.N.L.; Dhanabal, S.P.; Rajendran, Rajan S. Pharmacodynamic and ethnomedicinal uses of weed speices in nilgiris, Tamilnadu State, India: A review. AJAR, 2013, 8, 3505-3527.
[6]
Liu, R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr., 2004, 134(12)(Suppl.), 3479S-3485S.
[http://dx.doi.org/10.1093/jn/134.12.3479S] [PMID: 15570057]
[7]
Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3(10), 768-780.
[http://dx.doi.org/10.1038/nrc1189] [PMID: 14570043]
[8]
Shanmugam, M.K.; Lee, J.H.; Chai, E.Z.; Kanchi, M.M.; Kar, S.; Arfuso, F.; Dharmarajan, A.; Kumar, A.P.; Ramar, P.S.; Looi, C.Y.; Mustafa, M.R.; Tergaonkar, V.; Bishayee, A.; Ahn, K.S.; Sethi, G. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds. Semin. Cancer Biol., 2016, 40-41, 35-47.
[http://dx.doi.org/10.1016/j.semcancer.2016.03.005] [PMID: 27038646]
[9]
Uifălean, A.; Schneider, S.; Ionescu, C.; Lalk, M.; Iuga, C.A. Soy isoflavones and breast cancer cell lines: Molecular mechanisms and future perspectives. Molecules, 2015, 21(1), E13.
[http://dx.doi.org/10.3390/molecules21010013] [PMID: 26703550]
[10]
Ganai, A.A.; Farooqi, H. Bioactivity of genistein: A review of in vitro and in vivo studies. Biomed. Pharmacother., 2015, 76, 30-38.
[http://dx.doi.org/10.1016/j.biopha.2015.10.026] [PMID: 26653547]
[11]
Sato, D.; Kondo, S.; Yazawa, K.; Mukudai, Y.; Li, C.; Kamatani, T.; Katsuta, H.; Yoshihama, Y.; Shirota, T.; Shintani, S. The potential anticancer activity of extracts derived from the roots of Scutellariabaicalensis on human oral squamous cell carcinoma cells. Mol. Clin. Oncol., 2012, 105, 468-474.
[PMID: 24649131]
[12]
Zhang, Z.; Wang, C.Z.; Du, G.J.; Qi, L.W.; Calway, T.; He, T.C.; Du, W.; Yuan, C.S. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int. J. Oncol., 2013, 43(1), 289-296.
[http://dx.doi.org/10.3892/ijo.2013.1946] [PMID: 23686257]
[13]
Liu, Y.L.; Zhang, G.Q.; Yang, Y.; Zhang, C.Y.; Fu, R.X.; Yang, Y.M. Genistein induces G2/M arrest in gastric cancer cells by increasing the tumor suppressor PTEN expression. Nutr. Cancer, 2013, 65(7), 1034-1041.
[http://dx.doi.org/10.1080/01635581.2013.810290] [PMID: 24053672]
[14]
Yang, Y.M.; Yang, Y.; Dai, W.W.; Li, X.M.; Ma, J.Q.; Tang, L.P. Genistein-induced apoptosis is mediated by endoplasmic reticulum stress in cervical cancer cells. Eur. Rev. Med. Pharmacol. Sci., 2016, 20(15), 3292-3296.
[PMID: 27467006]
[15]
Banerjee, S.; Li, Y.; Wang, Z.; Sarkar, F.H. Multi-targeted therapy of cancer by genistein. Cancer Lett., 2008, 269(2), 226-242.
[http://dx.doi.org/10.1016/j.canlet.2008.03.052] [PMID: 18492603]
[16]
Sahin, K.; Tuzcu, M.; Basak, N.; Caglayan, B.; Kilic, U.; Sahin, F.; Kucuk, O. Sensitization of cervical cancer cells to cisplatin by genistein: the role of NFκB and Akt/mTOR signaling pathways. J. Oncol., 2012, 2012, 461562.
[http://dx.doi.org/10.1155/2012/461562] [PMID: 23056046]
[17]
Wang, J.C. DNA topoisomerases. Annu. Rev. Biochem., 1996, 65, 635-692.
[http://dx.doi.org/10.1146/annurev.bi.65.070196.003223] [PMID: 8811192]
[18]
Mizushina, Y.; Shiomi, K.; Kuriyama, I.; Takahashi, Y.; Yoshida, H. Inhibitory effects of a major soy isoflavone, genistein, on human DNA topoisomerase II activity and cancer cell proliferation. Int. J. Oncol., 2013, 43(4), 1117-1124.
[http://dx.doi.org/10.3892/ijo.2013.2032] [PMID: 23900272]
[19]
Brown, C.A.; Bogers, J.; Sahebali, S.; Depuydt, C.E.; De Prins, F.; Malinowski, D.P. Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. J. Oncol., 2012, 2012, 289315.
[http://dx.doi.org/10.1155/2012/289315] [PMID: 22481919]
[20]
Suzuki, K.; Yahara, S.; Hashimoto, F.; Uyeda, M. Inhibitory activities of (-)-epigallocatechin-3-O-gallate against topoisomerases I and II. Biol. Pharm. Bull., 2001, 24(9), 1088-1090.
[http://dx.doi.org/10.1248/bpb.24.1088] [PMID: 11558576]
[21]
Guarino, C.; Simone, L.D.; Santoro, S. Ethnobotanical study of the Sannio area, campania, southern Italy. Ethnobot. Res. Appl., 2008, 6, 255-17.
[http://dx.doi.org/10.17348/era.6.0.255-317]
[22]
Bouziane, A.; Bakchiche, B.; Dias, M.I.; Barros, L.; Ferreira, I.C.F.R.; AlSalamat, H.A.; Bardaweel, S.K. Phenolic compounds and bioactivity of Cytisus villosus pourr. Molecules, 2018, 23(8), 2-12.
[http://dx.doi.org/10.3390/molecules23081994] [PMID: 30103409]
[23]
Chaitanya, M.V.N.L.; Suresh, P.; Dhanabal, S.P.; Jubie, S. Human topopoisons from weeds: A review. Curr. Tradit. Med., 2018, 4, 15-26.
[http://dx.doi.org/10.2174/2215083804666180123153001]
[24]
Khakimov, B.; Tseng, L.H.; Godejohann, M.; Bak, S.; Engelsen, S.B. Screening for triterpenoid saponins in plants using hyphenated analytical platforms. Molecules, 2016, 21(12), 1614-1633.
[http://dx.doi.org/10.3390/molecules21121614] [PMID: 27886152]
[25]
Chaitanya, M.V.N.L.; Dhanabal, S.P.; Jubie, S.; Pavithra, M. Phytochemical, cytotoxic investigation and molecular docking studies of cytisusscoparius link for its dual human topo poisoning (I & II) activity. J. Harmo Res. Pharm., 2016, 5, 16-31.
[26]
Tansi, S.; Kokdil, G.; Karaman, S.; Toncer, O.; Yilmaz, H. Variation in ruscogenin contents in Ruscus aculeatus L. growing wild in Southern Turkey. Asian J. Chem., 2007, 19, 3015-3022.
[27]
Peneva, B.; Krasteva, I.; Nikolov, S.; Minkov, E. HPTLC densitometric determination of ruscogenins in dry extract of Ruscus aculeatus L. Pharmazie, 2000, 55(7), 541-542.
[PMID: 10944787]
[28]
Dhanabal, S.P.; Jubie, S.; Chaitanya, M.V.N.L. Isolation & Characterization of topo-poisons from Arthrospira Platensis: an in-silico approach. Pharm. Lett., 2016, 8, 165-175.
[29]
Rahman, H.S.A.; Wan-Ibrahim, W.S.; Ismail, T.N.N.T.; Mohd-Salleh, S.F.; Pak-Kai Wong, M.; Samad, M.R.A.; Hasim, M.N.M. Phytocompounds of Anonna muricata leaves extract and cytotoxic effects on breast cancer cells. Asian Pac. J. Trop. Med., 2018, 11, 659-665.
[http://dx.doi.org/10.4103/1995-7645.248337]
[30]
Pozarowski, P.; Darzynkiewicz, Z. Analysis of cell cycle by flow cytometry. Methods Mol. Biol., 2004, 281, 301-311.
[http://dx.doi.org/10.1385/1-59259-811-0:301] [PMID: 15220539]
[31]
Nitiss, J.L.; Soans, E.; Rogojina, A.; Seth, A.; Mishina, M. Topoisomerase assays. Curr. Protocols Pharmacol., 2012, Chapter 3, 3-10.
[PMID: 22684721]
[32]
Agerbirk, N.; Olsen, C.E.; Bibby, B.M.; Frandsen, H.O.; Brown, L.D.; Nielsen, J.K.; Renwick, J.A.A.A. A saponin correlated with variable resistance of Barbarea vulgaris to the diamondback moth Plutella xylostella. J. Chem. Ecol., 2003, 29(6), 1417-1433.
[http://dx.doi.org/10.1023/A:1024217504445] [PMID: 12918925]
[33]
Wang, F.; Jiang, K.; Li, Z. Purification and identification of genistein in Ginkgo biloba leaf extract. Se Pu, 2007, 25(4), 509-513.
[http://dx.doi.org/10.1016/S1872-2059(07)60019-4] [PMID: 17970108]
[34]
Notarnicola, M.; Messa, C.; Orlando, A.; D’Attoma, B.; Tutino, V.; Rivizzigno, R.; Caruso, M.G. Effect of genistein on cholesterol metabolism-related genes in a colon cancer cell line. Genes Nutr., 2008, 3(1), 35-40.
[http://dx.doi.org/10.1007/s12263-008-0082-5] [PMID: 18850198]
[35]
Zou, H.; Zhan, S.; Cao, K. Apoptotic activity of genistein on human lung adenocarcinoma SPC-A-1 cells and preliminary exploration of its mechanisms using microarray. Biomed. Pharmacother., 2008, 62(9), 583-589.
[http://dx.doi.org/10.1016/j.biopha.2007.12.010] [PMID: 18295443]
[36]
Yamaguchi, M.; Weitzmann, M.N. The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity. Int. J. Mol. Med., 2009, 23(2), 297-301.
[PMID: 19148557]
[37]
Zhou, N.; Yan, Y.; Li, W.; Wang, Y.; Zheng, L.; Han, S.; Yan, Y.; Li, Y. Genistein inhibition of topoisomerase II alpha expression participated by Sp1 and Sp3 in HeLa cell. Int. J. Mol. Sci., 2009, 10(7), 3255-3268.
[http://dx.doi.org/10.3390/ijms10073255] [PMID: 19742137]
[38]
Kar, I.; Majumder, H.K.; Chattopadhyaya, R. Extracts of seven indian plants inhibit human topoisomerase I and partially inhibit human topoisomerase II. Mol Enz Drug, 2017, 3, 1-8.
[39]
Kintzios, S.E. Terrestrial plant derived anticancer agents and plants used in anticancer research. Crit. Rev. Plant Sci., 2006, 25, 79-13.
[http://dx.doi.org/10.1080/07352680500348824]
[40]
Wang, J.C. Untangling the Double Helix, 1st ed; Cold Spring Harbor Laboratory Press: New York, 2009.
[41]
Chen, A.Y.; Liu, L.F. DNA topoisomerases: EAbout 5 g of sample was loaded onto a flash mssential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol., 1994, 34, 191-218.
[http://dx.doi.org/10.1146/annurev.pa.34.040194.001203] [PMID: 8042851]
[42]
Kim, S.I.; Lee, S.H.; Lee, E.S.; Lee, C.S.; Jahng, Y. New topoisomerases inhibitors: synthesis of rutaecarpine derivatives and their inhibitory activity against topoisomerases. Arch. Pharm. Res., 2012, 35(5), 785-789.
[http://dx.doi.org/10.1007/s12272-012-0504-1] [PMID: 22644846]